1. Stocks
  2. Mankind Pharma Ltd.
  3. Swot
swot-logo

Mankind Pharma Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Mankind Pharma Ltd. has 17 Strengths, 6 Weaknesses, 2 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Consistent Highest Return Stocks over Five Years - Nifty500

Relative Outperformance versus Industry over 1 Month

Expensive Performers (DVM)

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Companies with Low Debt

Increasing Revenue every quarter for the past 3 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

RSI indicating price strength

High Volume, High Gain

Top Gainers

Volume Shockers

Promoter decreasing their shareholding

PE higher than Industry PE

Promoter holding decreased by more than -2% QoQ

High PE (PE > 40)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Stocks Underperforming their Industry Price Change in the Quarter

FII / FPI or Institutions increasing their shareholding

MFs increased their shareholding last quarter

Companies with high market cap, lower public shareholding

High Piotroski Score - Companies with strong financials

Rising Delivery Percentage Compared to Prev Day

Expensive Performers (DVM)

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Decline in Net Profit with falling Profit Margin (QoQ)